← The Anti-Spin Read

FDA advances peptide push to White House

2026-10-16T18:01:12.304Z · framed 2026-10-16T19:08:02.766Z · 2 outlets covered

The FDA has submitted an interim access policy regarding peptide drugs to the White House for review. This policy aims to broaden access to a class of injectable drugs that have gained attention through Robert F. Kennedy Jr.

Coverage

• The Hill — FDA advances peptide push to White House
• The Independent — Trump administration advances plan for peptide drugs favored by RFK Jr.